Please login to the form below
Outcomes shape the new payer networks for pharma
The definition of the payer and the way in which healthcare spending decisions are made is changing, as complex networks of payers and clinicians become the new stakeholders with which the pharma industry must engage to successfully ensure market access for medicines through proof of cost-effectiveness. In this white paper from Consult, part of established research provider All Global, these evolving payer networks across the US and Europe are analysed, in order to provide pharma with clear strategic advice.
Downloads
Outcomes shape the new payer networks for pharma
PDF File: 389.5 KB
Company Details
Consult
020 7729 1400
Address:
The Tea Buidling
56 Shoreditch High Street
London
E1 6JJ
Latest content on this profile
- Outcomes shape the new payer networks for pharma
- The definition of the payer and the way in which healthcare spending decisions are made is changing, as complex networks of payers and clinicians become the new stakeholders with which the pharma industry must engage to successfully ensure market access for medicines through proof of cost-effectiveness.
In this white paper from Consult, part of established research provider All Global, these evolving payer networks across the US and Europe are analysed, in order to provide pharma with clear strategic advice.
Consult
